Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change RBC Capital analysts reiterated a Outperform rating on IDEX Corporation (NYSE:IEX) on July 30, 2026. Market Context IDEX Corporation operates in the Industrials…
Read moreRating Change Stifel analysts reiterated a Buy rating on IDEX Corporation (NYSE:IEX) on July 30, 2026. Market Context IDEX Corporation operates in the Industrials sector. The…
Read moreRating Change TD Cowen analysts reiterated a Buy rating on IDEX Corporation (NYSE:IEX) on July 30, 2026. Market Context IDEX Corporation operates in the Industrials sector. The…
Read moreRating Change B. Riley Securities analysts reiterated a Neutral rating on Federal National Mortgage Association (OTC:FNMFM) on July 30, 2026. Market Context Federal National…
Read moreRating Change RBC Capital analysts reiterated a Sector Perform rating on W. P. Carey Inc.
Read moreRating Change Evercore ISI Group analysts reiterated a In-Line rating on W. P. Carey Inc.
Read moreRating Change Goldman Sachs analysts reiterated a Neutral rating on Universal Health Services, Inc. (NYSE:UHS) on July 30, 2026. Market Context Universal Health Services, Inc.
Read moreRating Change Wells Fargo analysts reiterated a Overweight rating on Omnicom Group Inc. (NYSE:OMC) on July 30, 2026. Market Context Omnicom Group Inc.
Read moreRating Change Citigroup analysts reiterated a Buy rating on Omnicom Group Inc. (NYSE:OMC) on July 30, 2026. Market Context Omnicom Group Inc.
Read moreRating Change Evercore ISI Group analysts reiterated a In-Line rating on Mid-America Apartment Communities, Inc. (NYSE:MAA) on July 30, 2026. Market Context Mid-America Apartment…
Read moreRating Change Wells Fargo analysts reiterated a Overweight rating on Target Corporation (NYSE:TGT) on July 30, 2026. Market Context Target Corporation operates in the Consumer…
Read moreRating Change Needham analysts reiterated a Buy rating on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) on July 30, 2026. Market Context Alnylam Pharmaceuticals, Inc.
Read moreRating Change Needham analysts reiterated a Buy rating on Fair Isaac Corporation (NYSE:FICO) on July 30, 2026. Market Context Fair Isaac Corporation operates in the Technology…
Read moreRating Change Wells Fargo analysts reiterated a Overweight rating on Fair Isaac Corporation (NYSE:FICO) on July 30, 2026. Market Context Fair Isaac Corporation operates in the…
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Fair Isaac Corporation (NYSE:FICO) on July 30, 2026. Market Context Fair Isaac Corporation operates in the…
Read moreRating Change Argus Research analysts downgraded Las Vegas Sands Corp. (NYSE:LVS) from Buy to Hold on July 30, 2026. Market Context Las Vegas Sands Corp.
Read moreRating Change BTIG analysts reiterated a Buy rating on Chipotle Mexican Grill, Inc. (NYSE:CMG) on July 30, 2026. Market Context Chipotle Mexican Grill, Inc.
Read moreRating Change Stephens & Co. analysts reiterated a Equal-Weight rating on Chipotle Mexican Grill, Inc. (NYSE:CMG) on July 30, 2026.
Read moreRating Change Morgan Stanley analysts reiterated a Equal-Weight rating on Chipotle Mexican Grill, Inc. (NYSE:CMG) on July 30, 2026. Market Context Chipotle Mexican Grill, Inc.
Read moreRating Change Evercore ISI Group analysts reiterated a Outperform rating on Chipotle Mexican Grill, Inc. (NYSE:CMG) on July 30, 2026. Market Context Chipotle Mexican Grill, Inc.
Read more
